Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Crystal arthritis: a new 'package of care' strategy for effective gout management.

× No keyword cloud information.

9 in total

1. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.

Authors: Lisa K Stamp; John L O'Donnell; Mei Zhang; Jill James; Christopher Frampton; Murray L Barclay; Peter T Chapman
Journal: Arthritis Rheum Date: 2011-02

Review 2. Treatment adherence in patients with gout.

Authors: Gérard Reach
Journal: Joint Bone Spine Date: 2011-07-02 Impact factor: 4.929

3. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.

Authors: Nicola Dalbeth; Sunil Kumar; Lisa Stamp; Peter Gow
Journal: J Rheumatol Date: 2006-08 Impact factor: 4.666

4. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

Authors: Yanyan Zhu; Bhavik J Pandya; Hyon K Choi
Journal: Arthritis Rheum Date: 2011-10

Review 5. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors: W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal: Ann Rheum Dis Date: 2006-05-17 Impact factor: 19.103

Crystal arthritis: a new 'package of care' strategy for effective gout management.

1. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.

Review 2. Treatment adherence in patients with gout.

3. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.

4. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

Review 5. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

6. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.

7. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

8. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.

9. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.